FindTrial
Sign In

Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trial

Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170612005
Enrollment
Unknown
Registered
2017-06-12
Start date
2016-02-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the efficacy of triamcinolone and bevacizumabwas measured in patients with Central Retinal Vein Occlusion Bevacizumab&#44

Interventions

intravitreal injection of triamcinolone,intravitreal injection of bevacizumab ,intravitreal injection of the combined triamcinolone and bevacizumab
Experimental Drug,Experimental Drug,Experimental Drug
triamcinolone ,bevacizumab,triamcinolone + bevacizumab

Sponsors

Urmia university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 73 Years

Inclusion criteria

Inclusion criteria: patients with CRVO and satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: use of macular photocoagulation and intravitreal injection of any drug .

Design outcomes

Primary

MeasureTime frame
recovery of patients with Central Retinal Vein Occlusion 3 months visual asscessment—

Secondary

MeasureTime frame
N/A N/A N/A—

Countries

Iran

Contacts

Public Contactmiad rajabzadeh

Faculty of medicine, urmia university of medical science,Urmia, Iran

miad.rajabzadeh3128@gmail.com+989142664745

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026